Maximus, Inc. $MMS Shares Purchased by Edgestream Partners L.P.

Edgestream Partners L.P. boosted its stake in shares of Maximus, Inc. (NYSE:MMS) by 196.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 54,039 shares of the health services provider’s stock after buying an additional 35,822 shares during the quarter. Edgestream Partners L.P. owned 0.10% of Maximus worth $3,794,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Parkside Financial Bank & Trust boosted its stake in shares of Maximus by 21.7% during the 2nd quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock worth $62,000 after acquiring an additional 157 shares in the last quarter. Verus Financial Partners Inc. raised its holdings in Maximus by 6.7% during the second quarter. Verus Financial Partners Inc. now owns 3,387 shares of the health services provider’s stock worth $244,000 after purchasing an additional 214 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after purchasing an additional 221 shares in the last quarter. UMB Bank n.a. grew its holdings in Maximus by 37.5% in the second quarter. UMB Bank n.a. now owns 833 shares of the health services provider’s stock valued at $58,000 after purchasing an additional 227 shares during the last quarter. Finally, Exchange Traded Concepts LLC grew its holdings in Maximus by 2.0% in the second quarter. Exchange Traded Concepts LLC now owns 11,870 shares of the health services provider’s stock valued at $833,000 after purchasing an additional 228 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

MMS has been the topic of several recent research reports. Zacks Research lowered shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 27th. Weiss Ratings upgraded shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Maximus presently has a consensus rating of “Moderate Buy” and an average target price of $90.00.

Maximus Trading Down 1.9%

Shares of MMS stock opened at $84.85 on Thursday. The company has a market capitalization of $4.62 billion, a price-to-earnings ratio of 15.26 and a beta of 0.56. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.77. The firm has a 50-day moving average price of $85.56 and a 200 day moving average price of $80.24. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $92.50.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.01). The firm had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.34 billion. Maximus had a return on equity of 25.23% and a net margin of 5.87%.Maximus’s revenue for the quarter was up .2% on a year-over-year basis. During the same period in the prior year, the business earned $1.46 earnings per share. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. Research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, December 1st. Shareholders of record on Friday, November 14th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend was Friday, November 14th. Maximus’s payout ratio is presently 21.58%.

Insiders Place Their Bets

In other Maximus news, insider Michelle F. Link sold 4,039 shares of the stock in a transaction on Wednesday, December 3rd. The stock was sold at an average price of $86.84, for a total transaction of $350,746.76. Following the transaction, the insider owned 19,542 shares of the company’s stock, valued at $1,697,027.28. This represents a 17.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 1.60% of the company’s stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.